Objective: To examine the expression of selected transcription factors involved in adipogenesis and genes related to lipid metabolism in abdominal subcutaneous and omental fat tissue. Research design and methods: We obtained subcutaneous and omental adipose tissue samples from 40 women undergoing abdominal hysterectomies (age: 4775 years; BMI 27.975.3 kg/m 2 ). We measured isolated adipocyte size and metabolism, and detailed measures of body fat accumulation and body fat distribution were obtained (dual-energy X-ray absorptiometry and computed tomography, respectively). Results: Adipocyte size of both subcutaneous and omental fat were increased with higher body fat mass values, with similar regression slopes in each compartment. In contrast, with higher body fat mass values, fat accumulation was progressively higher in the subcutaneous than in the visceral fat compartment, suggesting hyperplasia in the subcutaneous fat compartment. Messenger RNA levels of CEBPa, PPARg2, SREBP1c and genes related to lipid metabolism (LPL, FABP4, DGAT1, DGAT2, PLIN and HSL) were significantly higher in subcutaneous than in omental fat tissue (Pp0.001 for all). Only subcutaneous expression of these genes tracked with obesity levels as reflected by significant positive associations between subcutaneous fat CEBPa, SREBP1c and DGAT2 expression and total body fat mass (r ¼ 0.37, r ¼ 0.41, r ¼ 0.57, respectively, Pp0,05), fat percentage (r ¼ 0.40, r ¼ 0.39, r ¼ 058, respectively, Pp0,05) and subcutaneous adipose tissue area (r ¼ 0.36, r ¼ 0.38, r ¼ 0.58, respectively, Pp0,05). Omental adipose tissue expression levels of these genes were not significantly related to adiposity measures. Conclusions: These results show that in obese women, hyperplasia is predominant in the subcutaneous fat depot, whereas fat cell hypertrophy is observed both in the omental and subcutaneous compartments.
Introduction
Accumulation of visceral adipose tissue is a critical predictor of metabolic disorders, such as insulin resistance, hyperinsulinemia, elevated triglyceride levels, low HDL-cholesterol and hypertension. 1, 2 The mechanisms responsible for body fat distribution patterns are, however, only partly elucidated. In women, adipocytes from the subcutaneous compartment are larger than those from omental fat. We also observed marked regional differences in adipose tissue metabolism in fat cells from these two depots, and these differences were relatively constant across the spectrum of adiposity values. 3 In men, omental and subcutaneous fat cells appear to reach similar sizes at relatively low body fatness values. Consequently, regional differences in fat cell metabolism are less apparent. 4 Sex differences in body fat distribution and adipocyte metabolism suggest that the storage capacity and propensity of fat cells to enlarge (fat cell hypertrophy) or to differentiate (fat cell hyperplasia) may be regulated in a depot-specific fashion.
Differentiation of preadipocytes and expansion of a given fat depot depend on the expression of a cascade of transcription factors that ultimately allow cells to develop into lipid-storing, mature adipocytes. Three classes of transcription factors have been identified that directly influence fat cell development. These include CCAAT/ enhancer binding proteins (C/EBP), the nuclear hormone receptor peroxisome proliferator-activated receptor g (PPARg) and the basic helix-loop-helix protein (ADD1/SREBP1c). Studies in adipogenic cell lines have shown that hormonal induction of differentiation is rapidly followed by expression of C/EBPb, C/EBPd, PPARg and C/EBPa. 5, 6 PPARg and C/EBPa induce each other's expression through a positive feedback loop. 7 The latter factors drive the expression of genes that are necessary for lipid synthesis. C/EBPa is required for induction and maintenance of PPARg levels. C/EBPa is also involved in the regulation of insulin sensitivity. 7 PPARg exists as two protein isoforms: PPARg1 that is found in fat cells and is present at lower levels in a variety of cells types, and PPARg2 that is adipocyte-specific. 8 PPARg was shown to induce adipogenesis, 9 and a number of adipocyte genes. 10 Several studies have now shown that PPARg is an important molecular determinant of adipose tissue distribution. [10] [11] [12] [13] Finally, the transcription factor SREBP1c does not initiate adipogenesis by itself but can promote adipogenesis and activate the expression of fatty acid synthase and lipoprotein lipase. 14 SREPB1c could bind to the PPARg promoter and activate PPARg expression. 15 How expression patterns of these genes relate to abdominal obesity in humans remains unclear. Depot-specific studies on the factors involved in cellular differentiation and lipid synthesis may provide a better insight into the molecular events underlying abdominal obesity. In the present study, we examined the expression of selected transcription factors and key genes related to adipocyte metabolism in abdominal subcutaneous and omental fat samples obtained from 40 women undergoing abdominal hysterectomies. We also measured isolated adipocyte size and metabolism, and detailed measures of body fat accumulation and body fat distribution were obtained (dual-energy X-ray absorptiometry (DEXA) and computed tomography, respectively). We tested the hypothesis that fat cell hyperplasia and hypertrophy, as reflected by adipogenic gene expression and cell size, would be predominant in subcutaneous rather than omental fat in our sample of women.
Subjects and methods

Subjects
Women of this study were recruited through the elective surgery schedule of the Gynecology Unit of the Laval University Medical Center. The study included 40 healthy women aged 39.6-61.7 year undergoing abdominal gynecological surgery. Women of the study elected for subtotal (n ¼ 1) or total abdominal hysterectomies (n ¼ 39), some with salpingo-oophorectomy of one (n ¼ 5) or two (n ¼ 15) ovaries. Reasons for surgery included one or more of the following: menorrhagia/menometrorrhagia (n ¼ 19), myoma/ fibroids (n ¼ 29), incapacitating dysmenorrhea (n ¼ 7), pelvic pain (n ¼ 1), benign cyst (n ¼ 9), endometriosis (n ¼ 4), adenomyosis (n ¼ 1), pelvic adhesions (n ¼ 4), endometrial hyperplasia (n ¼ 3) or polyp (n ¼ 2) and ovarian thecoma (n ¼ 1). Hormonal status was available for 37 women: 21 were premenopausal, 8 were perimenopausal; 4 of the latter used hormone replacement therapy, 8 were post-menopausal; 4 of the latter used a GnRH agonist. This study was approved by the medical ethics committees of Laval University and Laval University Medical Center. All subjects provided written informed consent before their inclusion in the study.
Body fatness and body fat distribution measurements These tests were performed on the morning of or within a few days before or after the surgery. Measures of total body fat mass, fat percentage and fat-free mass were determined by DEXA using a Hologic QDR-2000 densitometer and the enhanced array whole-body software V5.73A (Hologic Inc., Bedford, MA, USA). Measurement of abdominal subcutaneous and visceral adipose tissue cross-sectional areas was performed by computed tomography as previously described, 16 using a GE Light Speed 1.1 CT scanner (General Electric Medical Systems, Milwaukee, WI, USA). Subjects were examined in the supine position, with arms stretched above the head. The scan was performed at the L4-L5 vertebrae level using a scout image of the body to establish the precise scanning position. The quantification of abdominal adipose tissue areas was done using the ImageJ 1.33u software (National Institutes of Health, USA). The intraabdominal cavity was delineated at the internal-most aspect of the abdominal and oblique muscle walls surrounding the cavity and the posterior aspect of the vertebral body. Deep subcutaneous adipose tissue area was defined as the area between the subcutaneous fascia and the muscle wall. This surface was measured by delineating the subcutaneous fascia across the whole surface of the scan. Superficial subcutaneous adipose tissue area was obtained by subtracting deep subcutaneous area from total subcutaneous area. Adipose tissue areas were highlighted and computed using an attenuation range of À190 to À30 Hounsfield units. The coefficients of variation between two measures from the same observer (n ¼ 10) were 0.0, 0.2, 3.0, 2.9 and 0.5 % for total, subcutaneous (total), superficial subcutaneous, deep subcutaneous and visceral adipose tissue areas, respectively.
Glucose and insulin determination
Glycemic status was assessed using fasting glucose and insulin measurements in pre-surgery blood samples. Plasma glucose was measured using the glucose oxidase method, and plasma insulin levels were determined by radioimmunoassay (Linco Research, St Charles, MO, USA). The HOMA 
Statistical analyses
Non-parametric Spearman's rank correlation coefficients were computed to quantify associations among adiposity measures, fat cell size as well as measures of omental or subcutaneous adipose tissue metabolism and mRNA abundance in each fat depot. Matched-pair t-tests were used to compare mRNA expression levels in omental vs subcutaneous adipose tissue. The rationale for using this procedure was based on the fact that samples of the study were actually paired, each patient providing one subcutaneous and one omental fat sample. Bonferoni corrections were performed in this analysis. Analyses were performed using the JMP statistical software (SAS Institute, Cary, NC, USA).
Results
Anthropometric characteristics, abdominal adipose tissue areas, blood lipid profile and measures of glucose homeostasis of the 40 women included in the study are shown in Table 2 . Women were 47.1 years old on average and were slightly overweight according to their mean body mass index . Adiposity values covered a wide range, with body fat percentages ranging from 19.6-47.5% (average 35.3%). Figure 1 shows the associations between total body fat mass and abdominal adipose tissue areas measured by computed tomography. With higher body fat mass values, the accumulation of fat was largely predominant in the subcutaneous compared to visceral adipose tissue compartment. The regression of subcutaneous adipose tissue area to total body fat mass was steeper than that of visceral adipose tissue area to total body fat mass (14.770.6 vs 4.170.4 cm 2 / kg) (Figure 1a) . In contrast, the relationship between total body fat mass and the average size of adipocytes in each compartment showed similar slopes (1. (Figure 2) . Figure 3 shows relative mRNA expression levels of selected genes in subcutaneous and omental adipose tissue. Transcription factors expressed during adipogenesis are represented in panel a. Messenger RNA levels of CEBPa, PPARg and SREBP1c were significantly higher (Po0.001) in the subcutaneous than in the omental fat compartment. We also quantified mRNA levels of genes related to lipid 
Genes
Accession number Primers Adipose tissue hypertrophy and hyperplasia R Drolet et al metabolism. As seen in panel b, mRNA levels of these genes were significantly higher in the subcutaneous compared to omental fat compartment for all genes tested (LPL, FAPB4, DGAT1, DGAT2, PLIN and HSL). Table 3 shows associations between adiposity variables and mRNA levels of the genes examined in subcutaneous and omental fat compartments. The presence of significant correlations was restricted to the subcutaneous fat compartment. Omental fat mRNA levels were not associated with any adiposity measure. DGAT2 expression in the subcutaneous fat compartment was positively associated with all adiposity variables examined. SREBP1c expression was also positively related to most of the adiposity variables (body weight, BMI, body fat mass, fat percentage, total and subcutaneous abdominal adipose tissue areas), with the exception of visceral adipose tissue area. Subcutaneous expression of CEBPb expression was significantly and positively related to body weight and BMI, whereas subcutaneous fat CEBPa expression was positively associated body fat mass, fat percentage, total and subcutaneous adipose tissue area. No correlation was found between with CEBPa expression and body weight, BMI or visceral adipose tissue area.
Associations between abdominal subcutaneous mRNA abundance of the genes examined and adipocyte cell diameter, LPL activity and lipolysis (basal and forskolinor isoproterenol-stimulated) are shown in Table 4 . Once again, subcutaneous expression of DGAT2 was positively and significantly related to most of the variables tested. No correlation was found between basal lipolysis and subcutaneous expression of all genes tested. Subcutaneous expression of SREBP1c was positively related to LPL activity and isoproterenol-(10 À5 mol/l) as well as forskolin-stimulated lipolysis in the same depot. PPARg expression in the subcutaneous compartment was positively associated to isoproterenol-stimulated lipolysis (10 À5 mol/l and 10 À6 mol/l).
Subcutaneous CEBPb expression level was positively correlated with adipocyte diameter and LPL activity, whereas, CEBPa was only related to forskolin-stimulated (10 À5 mol/l) lipolysis. No correlation was found for omental gene expression and any of the variables tested (not shown). Analyses were performed by excluding menopausal women (n ¼ 8). Depot differences in gene expression levels as well as correlation patterns between gene expression and adiposity measures were unaffected. As a result of reduced statistical power, several correlations between subcutaneous gene expression levels and measures of LPL activity or lipolysis only tended to be significant when excluding these women.
Discussion
The aim of the present study was to examine depot-specific expression patterns of selected genes related to adipocyte differentiation or lipid metabolism in subcutaneous and omental fat tissue in women. We tested the hypothesis that Adipose tissue hypertrophy and hyperplasia R Drolet et al fat cell hyperplasia and hypertrophy, as reflected by adipogenic gene expression and cell size, would be predominant in subcutaneous rather than omental fat in our sample of women. As expected, the present study clearly shows that obese women are prone to accumulate fat in the subcutaneous compartment rather than in the visceral compartment. On the other hand, we found that cell size in both depots was related to total body fat mass with similar regression slopes, suggesting that subcutaneous tissue is characterized by increased fat cell hyperplasia in addition to hypertrophy of existing cells. Accordingly, expression levels of adipogenic genes were higher in subcutaneous than in omental fat, and only subcutaneous levels of these genes tracked with obesity. These results show that in obese women, hyperplasia is predominant in the subcutaneous fat depot, whereas fat cell hypertrophy is observed both in the omental and subcutaneous compartments. This is the first study to examine omental and subcutaneous fat adipogenic gene expression patterns in conjunction with computed tomography body fat distribution and fat cell size measurements in both compartments. A gain in adipose tissue mass results from an increase in adipocyte cell size (hypertrophy), adipocyte cell number (hyperplasia), or both. 23 Adipocyte volume reflects a balance between lipogenesis and lipolysis, whereas adipocyte number is determined by the recruitment of adipocyte precursor cells to become mature, lipid-accumulating adipocytes. Our results have shown a marked difference in, on the one hand, the regression of adipocyte size to total body fat mass, and on the other, the regressions of adipose tissue areas and total body fat mass. The fact that the regression slopes of subcutaneous and omental fat cell size were parallel indirectly suggest that obese women have proportionately larger adipocytes in both fat compartments compared to lean women. Conversely, the fact that the regression of subcutaneous adipose tissue area was much steeper than that of visceral adipose tissue area with total body fat mass Adipose tissue hypertrophy and hyperplasia R Drolet et al suggests that subcutaneous fat is hyperplasic in obese women. Accordingly, we found important differences between omental and subcutaneous expression of genes related to fat cell differentiation and lipogenesis. We examined mRNAs for 5 transcription factors that are known to play a significant role in adipocyte differentiation (CEBPa, CEBPb, CEBPd, PPARg and SREBP1c), and found higher expression of CEBPa, PPARg2 and SREBP1c in abdominal subcutaneous fat. These findings are also consistent with the notion that the recruitment of new fat cells occurs at greater rates in the subcutaneous depot than in omental fat. The expression profile of six genes related to lipid metabolism (LPL, FABP4, DGAT1, DGAT2, PLIN and HSL) in the subcutaneous and omental fat tissues, which were all significantly more abundant in the subcutaneous fat compartment, also supports the finding of adipogenic activity of subcutaneous fat in women. Several studies are concordant with our findings. Tchkonia et al. 24 have shown that adipose tissue contains two different adipocyte populations that are regionally distinct in their replicative capacity and adipogenesis. Interestingly, the subtype with the lower capacities for replication, lipid accumulation and C/EBPa expression was most abundant in the omental preadipocyte population. In lean women, the percentage of committed preadipocytes in the subcutaneous compartment reached 30% of the stromovascular cell fraction, 25 whereas, the number of committed preadipocytes was decreased in obese women and represented only 10% of the total number of the stromovascular cells. 26 These results suggest that committed preadipocyte availability decreases as adiposity increases. 25 The decreased number of committed preadipocytes in abdominal subcutaneous tissue of obese women may be due to the differentiation rates of existing preadipocytes and the formation of new fat cells with obesity. Our results are consistent with this hypothesis. Depot-specific expression of genes involved in adipocyte differentiation and fat tissue expansion has been examined in several studies. Giusti et al. 27 have shown that SREBP1c and CEBPa were significantly more abundant in subcutaneous than in visceral adipose tissue of obese women. However, the same group also showed in a sample of severely obese women that only PPARg1, not PPARg2, was more abundant in the subcutaneous compartment. 11 The fact that our study included women covering the range from lean to obese may explain this difference. Also consistent with our results, Lefebvre et al. 12 have shown that PPARg2 expression level was twofold higher in the subcutaneous than in the omental fat compartment in subjects with a BMI lower than 30 kg/m 2 . Some studies have also reported that CEBPa and PPARg expression was higher in preadipocytes from the subcutaneous depot than in preadipocytes isolated from omental fat. [28] [29] [30] Recent studies using microarray analysis have also shown that fat tissue or preadipocytes from omental and subcutaneous fat depots have distinct expression profiles. 30, 31 Differences in the expression of adipogenic genes in fat cells from different depots could contribute to regional fat distribution. PPARg plays a critical role in the development and distribution of adipose tissue. Mice with a dominant negative mutation in PPARg show altered development of subcutaneous fat pads, revealing a role for PPARg in controlling adipose tissue localization and distribution. Ablation or impaired function of PPARg specifically in adipose tissue resulted in an insulin-resistant lipodystrophic phenotype. 32 In humans, PPARg agonists improve the metabolic profile by stimulating the recruitment of fat cells specifically in the subcutaneous fat compartment. 33, 34 Our results are consistent with this effect of PPARg agonists in subcutaneous fat and indirectly suggest that intrinsic, depot-specific properties of adipose tissues, such as the capacity for hyperplasia, determine their respective responsiveness to such stimulation. The cellular composition of adipose tissue changes as adiposity increase. For example, macrophage infiltration is more important in omental fat than in subcutaneous fat and increases with BMI. 35, 36 Considering the fact that macrophages could represent an important percentage of cells in obese men and women, this could contribute to the differential expression of genes implicated in adipogenesis or lipid metabolism. In the present study, however, women covered a wide range of BMI values, which should attenuate the possible contribution of macrophages in the expression profiles examined. Subcutaneous and visceral adipose tissues differ in their physiological, metabolic properties and potential contribution to disease risk factors. Subcutaneous fat is organized into tightly packed lobules, whereas fat in visceral depots is found in lobules that are more irregular, and less well organized. Subcutaneous adipose tissue is relatively stable metabolically as compared to the visceral fat compartment. We recently postulated that the subcutaneous depot represents a primary fat depot. 37 We also suggested that the expansion of the subcutaneous fat depot occurred under hormonal and energetic conditions that favored such fat storage (for example, puberty in women), and that when the storage capacity of the subcutaneous depot became limiting, expansion of the secondary fat depots, including visceral fat, took place. Adipocyte number and anatomical localization are major determinants of metabolic consequences related to obesity. 38 A higher storage capacity of the subcutaneous compartment in women could theoretically prevent fat accumulation in the visceral compartment, and explain the lower prevalence of metabolic disturbances in women compared to men.
In the present study, we used computed tomography to separate deep and superficial adipose tissue areas. These anatomically distinct abdominal subcutaneous fat compartments are separated by a fascial plane (termed superficial or subcutaneous fascia), which is circumferential and fuses with the underlying muscle wall in radiating strands at particular anatomic locations. 39, 40 Important morphological
Adipose tissue hypertrophy and hyperplasia R Drolet et al differences have been observed between these two adipose tissue layers. 40 In the present study, no difference was observed in regressions of total body fat mass to either superficial subcutaneous or deep subcutaneous adipose tissue areas. These results indirectly suggest that obese women accumulate lipids in both fat compartments at similar rates without distinction between the deep or superficial subcutaneous layer. Our adipose tissue samples were derived from the superficial layer in the present study. Future studies examining both subcutaneous fat compartments separately may help in clearly determining whether the superficial or deep fat layer is more prone to fat cell hyperplasia. Several limitations of the present study should be acknowledged. The cross-sectional design of this study does not provide information as to the directionality of the associations. Thus, it is not possible to determine how weight gain or loss affect the expression of the different genes examined, or how this could affect the size and metabolism of fat cells in each depot. Considering the fact that the sampling of omental fat requires general anesthesia, long-term longitudinal studies on this depot are not feasible. Another limitation to our study is the fact that protein levels were not measured. This is due to the limited size of fat biopsies obtained. Our study included, however, many measures of adiposity and fat cell function such as tomography, body composition and fat cell size or adipocyte characteristics in each compartment. In addition, several different genes were examined. The very consistent correlation patterns observed support the validity and relevance of our findings. Finally, the lack of men in our sample also appears as a limitation. Further studies in men are clearly required to extend our hypothesis to both sexes.
